SCHEMBL6496632

SCHEMBL6496632

CCOC(=O)c1nc[c]n1-c1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.49
GAA P10253 3/20 0.49
MAPT P10636 3/20 0.49
TP53 P04637 1/20 0.47
ALOX12 P18054 1/20 0.47
PDE4D Q08499 1/20 0.47
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46
HPGD P15428 2/20 0.45
GABRA2 P47869 1/20 0.45
GABRB2 P47870 1/20 0.45
KDM4E B2RXH2 2/20 0.44
HSD17B10 Q99714 1/20 0.44
TSHR P16473 1/20 0.44
SMN1; SMN2 Q16637 2/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
ADORA2A P29274 1/20 0.42
ADORA1 P30542 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25780013 0.72 ALDH1A1 (0.56) ALDH1A1GAAMAPTTP53ALOX12
SCHEMBL20028539 0.72 ALDH1A1 (0.57) ALDH1A1GAAMAPTTP53ALOX12
SCHEMBL20028039 0.72 GABRA2 (0.52) ALDH1A1GAAMAPTTP53ALOX12
SCHEMBL8162436 0.70 TP53 (0.62) ALDH1A1GAAMAPTTP53ALOX12
SCHEMBL22920713 0.70 PDE4D (0.58) ALDH1A1GAAMAPTTP53ALOX12
SCHEMBL20028763 0.70 GABRA2 (0.59) ALDH1A1GAAMAPTTP53ALOX12
SCHEMBL8669564 0.69 GABRA2 (0.51) ALDH1A1GAAMAPTTP53ALOX12
SCHEMBL14269199 0.68 GAA (0.61) ALDH1A1GAAMAPTTP53ALOX12
SCHEMBL28728715 0.68 NPC1 (0.62) ALDH1A1GAAMAPTTP53ALOX12
SCHEMBL20028541 0.68 MAPT (0.55) ALDH1A1GAAMAPTTP53ALOX12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050014765-A1 Aryl-heteroaromatic products, compositions comprising them and use AVENTIS PHARMA S.A. (FR) 2005-01-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050014765-A1 Aryl-heteroaromatic products, compositions comprising them and use AHR, ARNT, MYC ALDH1A1 240/4885GAA 1202/4885MAPT 3583/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.